# Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.

> **NCT00658684** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 153 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** fesoterodine fumarate

## Key facts

- **NCT ID:** NCT00658684
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658684, "Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00658684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*